Onconova Therapeutics, Inc. (ONTX) Social Stream
ONCONOVA THERAPEUTICS INC (ONTX) Price Targets From Analysts
Use the tables below to see what analysts covering ONCONOVA THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-13 | 4 | $59.97 | $11 | $35.485 | $0.785 | 4420.38% |
| 2022-05-13 | 4 | $11 | $7 | $9 | $0.785 | 1046.5% |
| 2022-11-15 | 3 | $11 | $7 | $9 | $0.785 | 1046.5% |
The Trend in the Analyst Price Target
ONTX's average price target has moved down $26.48 over the prior 14 months.
ONTX reports an average of 672.02% for its upside potential over the past 34 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-13 | 3 | 11 | 7 | 9 | 1.08 | 733.33% |
| 2022-05-13 | 4 | 11 | 7 | 9 | 1.08 | 733.33% |
| 2022-06-01 | 3 | 11 | 7 | 9 | 1.14 | 689.47% |
| 2022-11-15 | 2 | 11 | 7 | 9 | 0.84 | 971.43% |
| 2022-11-15 | 3 | 11 | 7 | 9 | 0.84 | 971.43% |
ONTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 13 months, ONTX's average broker recommendation rating improved by 0.33.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ONCONOVA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 488.85% of all US stocks.
- ONTX has a greater number of analysts covering the stock than 51.55% of all US stocks.
- ONTX has a greater average analyst price target than 221.39% of stocks in the small market cap category.
- In terms of how ONCONOVA THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -160% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ONCONOVA THERAPEUTICS INC are LUMO, CBIO, and ADXS.
View All Top Stocks by Price Target
What is the outlook for ONTX? Use POWR Ratings for clearer insight into price direction.